期刊文献+

肿瘤基因联合治疗的研究进展

Progresses of combined gene therapy on tumor
下载PDF
导出
摘要 近年来,基因治疗恶性肿瘤渐渐成为研究的热点,并在治疗中体现出了不可估量的前景。相对肿瘤发生发展的复杂性和多因性,多基因联合治疗已经成为基因治疗的发展方向。 There has been more and more reports which research the therapy of tumor using of combined gene. Combined gene can overcome the fault of single gene and have better effectiveness. It's the future of gene therapy and have promising perpective.
出处 《海峡药学》 2007年第6期1-4,共4页 Strait Pharmaceutical Journal
关键词 肿瘤 基因治疗 联合 Tumor Genetherapy Combined
  • 相关文献

参考文献26

  • 1Seno M,Hinuma S,Onda H,et al.A hybrid protein between INF-r and IL-2[J].FEBS Lett 1986,199:187 ~92.
  • 2费嘉,张洹.血管内皮生长因子反义核酸与高三尖杉酯碱联用对白血病细胞的增敏效应[J].广东医学,2005,26(4):458-460. 被引量:3
  • 3Kassam A,Der SD,Mogridge J.Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin[J].Cellular microbiology,1462 ~5814,2005,7:2 ~ 14.
  • 4Gokoh MK,ishimoto SO,ka S,et al.2-Arachidonoylglycerol,and endogenous cannabinoid receptor ligand,induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells[J].The Biochemical Journal,0264-6021,2005,386 ~ 393.
  • 5Krishna CM,Kegelaerl G,Rubin S,et al.Combined Fourier transform infrared and Raman spectroscopic identification approach for identification of multidrug resistance phenotype in cancer cell lines[J].Biopolymers,2006,82:5 ~ 14.
  • 6Addison CL,Bramson JL,Hitt MM,et al.Intratumoral coinjection of adenoviral vectors expressing IL 2 and IL 12 results in enhanced frequency of regression of injected and untreated distal tumors[J].Gene Ther,1998,5:1400 ~ 1409.
  • 7Uagliani M,Rodolfo M,Cavallo F,et al.Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells[J].Cancer Res,1996,56:467 ~ 470.
  • 8刘勇,胡大荣,谭晓华,胡学玲,范公忍,韩聚强,吴忆贫.IL-2和IL-12联合基因治疗小鼠肝癌的实验研究[J].第三军医大学学报,2004,26(12):1071-1074. 被引量:5
  • 9姜洁,梁华茂,孔北华,马道新,江森.IL-12协同B7-1诱导机体抗肿瘤免疫的实验研究[J].肿瘤,2004,24(2):128-131. 被引量:4
  • 10Susan C.,Modesitt,Pedro Ramirez,et al.In Vitro and in Vivo Adenovirus-mediated p53 and p16 Tumor Suppressor Therapy in Ovarian Cancer[J].Clin Cancer Res,2001,7:1487 ~1489.

二级参考文献48

  • 1费嘉,张洹,韩忠朝.血管内皮生长因子基因反义核酸体外抑制K562细胞生长及机理研究[J].中国病理生理杂志,2004,20(10):1769-1772. 被引量:4
  • 2胡亮,钱关祥,沈文红,许伟榕,张腾飞,陈诗书.PA317产生高滴度带有人TNF-α基因逆转录病毒的研究[J].中国肿瘤生物治疗杂志,1995,2(3):235-238. 被引量:17
  • 3[1]Tartour E, Mehtali M, Sastre-Garau X, et al. Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings[J]. Br J Cancer, 2000, 83(11): 1454-1461.
  • 4[2]He P, Tang Z Y, Ye S L, et al. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells[J]. J Exp Clin Cancer Res, 2000, 19(2): 183-187.
  • 5[3]Lucas M L, Heller L, Coppola D, et al. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16. F10 melanoma[J]. Mol Ther, 2002, 5(6): 668-675.
  • 6[4]Li D, Shugert E, Guo M, et al. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2001, 127(11): 1319-1324.
  • 7[5]Yamashita Y I, Shimada M, Hasegawa H, et al. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model[J]. Cancer Res, 2001, 61(3): 1005-1012.
  • 8[6]Kahlil J, Andrews, Antoni R, et al. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells[J]. Cancer Res, 2000, 60(22): 6457-6464.
  • 9[7]Ruiz J, Mazzolini G, Sangro B, et al. Gene therapy of hepatocellular carcinoma[J]. Dig Dis, 2001, 19(4): 324-332.
  • 10[8]Lui V W, Falo LD Jr, Huang L, et al. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo[J]. J Gene Med, 2001, 3(4): 384-393.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部